RecruitingACTRN12619000740190

Studies of apnoea in the newborn: Delivery of positive inflating pressure as early rescue

The SANDPIPER study: Delivery of positive inflation pressure as early rescue triggered by respiratory pause in preterm infants <30 weeks gestation on bubble CPAP


Sponsor

University of Tasmania

Enrollment

20 participants

Start Date

Jul 16, 2019

Study Type

Interventional

Conditions

Summary

We will investigate whether delivery of positive inflation pressure (PIP) (singly or repeated), triggered by a 3 second pause in respiration, can re-establish breathing efforts in preterm infants on continuous positive airway pressure (CPAP), a form of non-invasive respiratory support. The study will involve infants born at <30 weeks gestation who require CPAP support, and are having episodes of respiratory pauses. We will conduct a 16 hours crossover study comparing the use of a device to generate PIP with standard CPAP support. The study will be in blocks of 4 hours (randomly assigned) in which PIP is delivered singly, repeatedly (up to 3), or not at all (standard CPAP). We hypothesise that PIP will improve the regularity of breathing, and shorten the duration of respiratory pauses.


Eligibility

Sex: Both males and femalesMax Age: 4 Monthss

Inclusion Criteria7

  • Birth gestation <30 weeks
  • Chronological age < /=4 months
  • Supported with bubble CPAP
  • Having frequent respiratory pauses 5+ seconds duration, resulting in episodes of hypoxia (SpO2 <85) and/or bradycardia (heart rate <100 bpm) at least twice per hour.
  • Research team available to commence study
  • Agreement of treating clinician that the infant is suitable for involvement in the study
  • Signed parental consent

Exclusion Criteria1

  • Change in mode of respiratory support, including use of non-triggered continuous non-invasive positive pressure ventilation (NIPPV) being contemplated in next 24 hours

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This will be a 16 hour crossover study consisting of 4 periods, each of 4 hours duration. Both the first and second halves of the study will consist of a control and intervention epoch at random. Duri

This will be a 16 hour crossover study consisting of 4 periods, each of 4 hours duration. Both the first and second halves of the study will consist of a control and intervention epoch at random. During each intervention epoch, positive inflating pressure (PIP) triggered by 3 seconds of apnoea will be delivered either singly (sPIP) or repetitively (rPIP, up to 3 inflations). The maximum pressure of 18 cmH2O will be delivered via a PIP generating device, coupled to the existing CPAP circuit. A minimum washout period of 15 minutes will occur between each epochs. To monitor fidelity, UTAS researchers will be on-site during intervention period. Additionally, CPAP pressures are measured and recorded throughout the 16 hour study period. Bedside staff are not required to monitor or manage the PIP generator beyond their usual interaction with the normal CPAP circuit.


Locations(1)

Royal Hobart Hospital - Hobart

TAS, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12619000740190


Related Trials